Nephros Management
Management criteria checks 2/4
Nephros' CEO is Robert Banks, appointed in May 2023, has a tenure of 1.58 years. total yearly compensation is $824.07K, comprised of 27.8% salary and 72.2% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth $104.30K. The average tenure of the management team and the board of directors is 1.9 years and 5.8 years respectively.
Key information
Robert Banks
Chief executive officer
US$824.1k
Total compensation
| CEO salary percentage | 27.8% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.7% |
| Management average tenure | 1.9yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)
Oct 03
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn
Jul 14Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates
May 13After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar
Dec 18At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Dec 14Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation
Sep 28US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results
Aug 13Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH)
Mar 25At US$8.37, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Mar 04Announcing: Nephros (NASDAQ:NEPH) Stock Increased An Energizing 131% In The Last Five Years
Jan 28Nephros sees Q4 revenue in-line with estimates,
Jan 12Nephros, Inc. (NASDAQ:NEPH) Insiders Increased Their Holdings
Dec 08Nephros EPS beats by $0.02, misses on revenue
Nov 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$929k |
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$1m |
| Dec 31 2023 | US$824k | US$229k | -US$2m |
Compensation vs Market: Robert's total compensation ($USD824.07K) is about average for companies of similar size in the US market ($USD646.54K).
Compensation vs Earnings: Insufficient data to compare Robert's compensation with company performance.
CEO
Robert Banks (49 yo)
1.6yrs
Tenure
US$824,065
Compensation
Mr. Robert Banks is President, Director & CEO of Nephros, Inc. from May 2023. Mr. Banks has a proven track record of delivering value through innovation and aligning the strengths of his organizations with...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.6yrs | US$824.07k | 0.66% $ 104.3k | |
| Chief Financial Officer | 1.1yrs | US$284.24k | no data | |
| Director of Operations | no data | no data | no data | |
| Director of Brand | 1.9yrs | no data | no data | |
| Vice President of Quality | 2.9yrs | no data | no data | |
| President of Aether Water Systems | 4.2yrs | no data | no data | |
| Controller | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
Experienced Management: NEPH's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.6yrs | US$824.07k | 0.66% $ 104.3k | |
| Director | 17.3yrs | US$34.64k | 0.98% $ 154.2k | |
| Independent Director | 6.3yrs | US$50.55k | 0.77% $ 121.6k | |
| Independent Director | 5.8yrs | US$34.64k | 0.46% $ 72.5k | |
| Independent Director | 2.3yrs | US$34.64k | 0.17% $ 26.4k |
5.8yrs
Average Tenure
53yo
Average Age
Experienced Board: NEPH's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 09:09 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nephros, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Wasserman | Benchmark Company |
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Anthony Vendetti | Maxim Group |